EU-Mercosur Trade Deal Could See Brazilian Drug Spending Soar

Free trade talks between the EU and South American countries in the Mercosur trade bloc are set to resume on Nov. 6 in Brasilia. Critics of the EU proposals on intellectual property say they would mean Brazil spending billions more on medicines.

BrazilianPill_1200x675
Drug spending in Brazil could soar thanks to Mercosur EU FTA

The next round of talks on a potential free trade deal between the European Union and the Mercosur countries in Latin America is set to run from Nov. 6-10 in the Brazilian capital Brasilia. Among the topics likely to be discussed are intellectual property rights, with critics claiming that EU proposals would introduce “TRIPS-plus” measures that would delay generic entry and cause Brazil to spend billions more on medicines.

The EU is negotiating the free trade deal with the four founding members of Mercosur – Argentina, Brazil, Paraguay and...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography